Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $7,407.00 |
|---|---|
| Enterprise Value | $-5,702,259.00 |
| Earnings per Share | $-0.07 |
| Beta | 1.22 |
| Outstanding Shares | 74,065,063 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2.18 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Golden Ally Lifetech Group, Inc., a company in its developmental stage, concentrates on innovating across advanced technologies, energy solutions, and medical equipment. Within the bioscience and sports medicine fields, it is actively de...